ResMed makes continuous and bilateral positive airway pressure machines for non-invasive treatment of sleep apnea - a condition in which the airway gets blocked multiple times while sleeping.

One highly effective treatment for obstructive sleep apnea is a CPAP (continuous positive airway pressure) machine. This ...

But the central driver of the investment thesis is ResMed's market for sleep apnoea devices, particularly continuous positive airway pressure (CPAP) machines. Put bluntly, the market size is huge ...

or CPAP, with another 34 million remaining undiagnosed. ResMed operates in over 140 countries with over 900 million people estimated to have sleep apnea globally, indicating the long runway for ...

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...

ResMed RMD is set to give its latest quarterly earnings report on Thursday, 2024-10-24. Here's what investors need to know before the announcement. Analysts estimate that ResMed will report an ...